Lindsay Bealor Greenleaf Discusses Massachusetts Medicaid Drug Plan with HealthLeaders

Health Policy & Access Strategy

June 29, 2018

Lindsay Bealor Greenleaf, director at ADVI Health, said "It's a relief to see the administration do the right thing and reject this waiver request, because if Massachusetts had gotten its way, Medicaid patients would have limited treatment choices and industry would doubt whether future deals struck with the government will hold up over time."

[el-text]

Written by John Commins

***excerpt***

Lindsay Bealor Greenleaf, director at ADVI Health, said “It’s a relief to see the administration do the right thing and reject this waiver request, because if Massachusetts had gotten its way, Medicaid patients would have limited treatment choices and industry would doubt whether future deals struck with the government will hold up over time.”

***end excerpt***

***

[/el-text]

View full article here


Reach out

Own your edge

We don’t just guide the market. We shape it. Map your market access moves with #ADVIIntelligence. Proven advantage. Unmatched partnership.